Zacks.com on MSN10h
Is Guardant Health (GH) Outperforming Other Medical Stocks This Year?
Here is how Guardant Health (GH) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
Guggenheim Reiterates “Buy” Rating for Guardant Health (NASDAQ:GH)
Guggenheim restated their buy rating on shares of Guardant Health (NASDAQ:GH – Free Report) in a report released on Monday ...
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Myriad Genetics (MYGN)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Elanco Animal Health (ELAN – Research Report) and Myriad ...
Myriad Genetics (MYGN) Receives a Buy from Craig-Hallum
In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Myriad Genetics (MYGN – Research Report). The ...
Miami Dolphins8h
Miami Dolphins Celebrate 15 Years of the Dolphins Cancer Challenge with Another Record-Breaking Event
The Miami Dolphins hosted the 15th edition of the Dolphins Cancer Challenge (DCC) on Saturday, February 22, uniting with the ...
Oncology Companion Diagnostic Market Size to Hit USD 10.60 Billion by 2032 – SNS Insider
Oncology Companion Diagnostic Market is poised for substantial growth driven by advancements in personalized medicine and targeted therapies.Pune, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oncology Companion ...
lifesciencesipreview7h
Natera loses $96m jury win as judge invalidates DNA test patents
Delaware federal judge reverses jury verdict in CareDx’s favour | Natera’s patents covering organ transplant testing ...